Part VII — Bioorganic and Special Topics

Four chapters:

  1. Carbohydrates — Structure, reactivity, and biological significance. Sugars are small molecules with large consequences.
  2. Amino Acids, Peptides, and Proteins — The chemistry of life's machines.
  3. Lipids, Terpenes, and Biosynthesis — How nature does organic chemistry, often better than we do.
  4. Organic Chemistry of Drug Design — How medicines are built from molecular principles.

What Part VII is and is not

Part VII is not a mini-biochemistry textbook. There is no metabolic-pathway memorization, no discussion of cofactors per se, no citric-acid-cycle deep dive. A good biochemistry course does those things better.

Part VII is organic chemistry of biological molecules — the reactivity of carbohydrates, the synthesis of peptides, the biosynthesis of terpenes, the mechanism of drug-target binding. We choose these four topics because they are where the mechanisms you have built over the first 31 chapters most directly explain what living systems do.

Three examples of how this shows up concretely:

  1. Carbohydrates. A six-carbon sugar like glucose has five stereocenters. Its open-chain form (an aldohexose) is an aldehyde with four hydroxyls, and it undergoes the characteristic reactions of both — hemiacetal formation (Chapter 25) explains why glucose spends 99% of its time in a cyclic pyranose form rather than the open chain. Every reaction of glucose in a cell is a carbonyl reaction you already know.

  2. Peptide synthesis. Amide bonds between amino acids are formed in the laboratory by nucleophilic acyl substitution (Chapter 26) on an activated ester intermediate — the activating reagents have names (HOBt, HATU, DCC) but the mechanism is the Chapter 26 one. In the ribosome, the same amide bond is formed by a different acyl transfer that is mechanistically analogous. Same electrons, different protein scaffold.

  3. Lipid biosynthesis. Cholesterol — a $C_{27}$ steroid with four fused rings and eight stereocenters — is built by the cell from the two-carbon unit acetyl-CoA through about twenty enzyme-catalyzed steps. Each step is a reaction you know: Claisen condensation, aldol reaction, $\beta$-keto decarboxylation, alkene isomerization, alkene cyclization (the famous squalene cyclase step is one of the most remarkable single reactions in biology). Biology builds extraordinary complexity from ordinary mechanisms.

Drug design (Chapter 35)

Chapter 35 is where the pharmaceutical progressive project culminates. The aspirin / ibuprofen / acetaminophen trio introduced in Chapter 1 returns here with full mechanistic explanations of how each one works — aspirin as an irreversible inhibitor of cyclooxygenase (its acetyl group transfers to a serine in the enzyme active site, a Chapter 26 mechanism happening in a protein), ibuprofen as a reversible competitive inhibitor, acetaminophen's more complicated story.

We also cover the drug-design decisions that followed the thalidomide tragedy — why modern drugs are developed as single enantiomers, how racemates are resolved, and the recent surprise that thalidomide itself has become a valuable scaffold for a new class of drugs (immunomodulatory agents and targeted protein degraders) that exploit its binding to the protein cereblon.

This chapter is deliberately practical. A pre-med student who finishes this chapter should have an accurate picture of what the first few years of pharmaceutical research look like — not memorizable factoids, but the thinking that takes a biological target and produces a drug candidate.

What Part VII will leave you able to do

  • Draw any monosaccharide in its linear (Fischer) and cyclic (Haworth, chair) forms, and interconvert them.
  • Explain the mechanism of every reaction a simple sugar undergoes — mutarotation, glycoside formation, oxidation, reduction, Fischer projection analysis.
  • Synthesize a tripeptide using modern solid-phase peptide-synthesis methodology, with the full coupling and deprotection mechanisms.
  • Understand the biosynthetic origin of a terpene or steroid from isoprene units and recognize the mechanism of each step.
  • Analyze a drug molecule: identify its functional groups, predict how it binds to its target, explain its pharmacokinetic behavior in terms of molecular properties.

What Part VII does not provide

  • A survey of all natural products. We cover sugars, amino acids, fatty acids, simple terpenes, and steroids because they are the four molecular classes that cover most of biology. Nucleic acids appear briefly in Chapter 33 (as peptide analogues) and more fully in Appendix C and the instructor guide. Alkaloids, polyketides, and non-ribosomal peptides are mentioned but not systematically developed.
  • Metabolic pathway memorization. If you want the full glycolysis-TCA-oxidative-phosphorylation picture, take biochemistry.
  • Detailed enzymology. Enzymes appear as stereospecific catalysts; mechanism-of-enzyme-action is only discussed when it illustrates a general principle (as with cyclooxygenase in Chapter 35).

Connections back and forward

  • Back to Part VI: every single reaction in Part VII is a carbonyl reaction, an $S_{N}2$, or an aromatic substitution — dressed up in biology's vocabulary.
  • Back to Part II: the stereochemistry of every biological molecule is an enantiomeric problem. Chapter 33 is where the $L$ and $D$ naming convention finally pays off.
  • Forward to Part VIII: the total-synthesis capstone in Chapter 38 uses a real natural-product target, drawing on the Part VII mechanisms in both directions (how the molecule is made biosynthetically, and how we would synthesize it in the lab).

Chapters in This Part